Vice President, Medicinal Chemistry
Current
Jun 2023 - Present
AeroLeads people directory · profile
Shon Pulley, Ph.D. Email & Phone Number
Principal and Owner at SolTerra Consulting LLC | Pharmaceutical R&D | Drug Discovery | External Collaborations
at
ROME Therapeutics
3 work emails found
@elanco.com
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Principal and Owner at SolTerra Consulting LLC | Pharmaceutical R&D | Drug Discovery | External Collaborations
Location
Trenton, South Carolina, United States
Who is Shon Pulley, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Shon Pulley, Ph.D. is listed as Principal and Owner at SolTerra Consulting LLC | Pharmaceutical R&D | Drug Discovery | External Collaborations at ROME Therapeutics, based in Trenton, South Carolina, United States. AeroLeads shows a work email signal at elanco.com and a matched LinkedIn profile for Shon Pulley, Ph.D..
Shon Pulley, Ph.D. previously worked as Vice President, Medicinal Chemistry at Rome Therapeutics and Senior Director Medicinal Chemistry at Rome Therapeutics. Shon Pulley, Ph.D. holds Ph.D., Chemistry from Colorado State University.
Company email context
Email format at ROME Therapeutics
This section adds company-level context without repeating Shon Pulley, Ph.D.'s masked contact details.
*@elanco.com
74% confidence
AeroLeads found 3 current-domain work email signals for Shon Pulley, Ph.D.. Compare company email patterns before reaching out.
Profile bio
About Shon Pulley, Ph.D.
I am a Pharmaceutical R&D leader with a passion for second order thinking in the design and execution of strategies to address the what? the why? and the how? in the advancement of innovation meeting customer needs. My team leadership principles are grounded in teamwork, trust and humility creating an engaged team environment. I have a diverse background in veterinary and human health leading scientific research and operational management. I excel at connecting the dots between science, capabilities, resources and operational excellence to meet corporate business objectives. I am a problem solver with high learning agility able to quickly identify and resolve issues, acquire and apply new knowledge.Experienced (+20 years) in drug discovery (medicinal chemistry) and early development including setting strategy, budget and resources for multi-functional and cultural teams (+50 FTEs direct/in-line) in chemistry, biology, drug disposition/safety, process/analytical technologies and laboratory management.Experience in building and managing external investigator collaborations, including technical and alliance management. Includes relationship building with industrial partners in collaboration with internal subject matter experts, and BD&L. Led global strategic initiatives resulting in improved efficiency and effectiveness across the enterprise.Diverse therapeutic/species experience (e.g., parasitology, pain, dermatology, metabolic, oncology, neuroscience etc.) involving formulating hypotheses, designing, and executing strategy resulting in 15 issued patents, author/co-author on 21 papers and 1 book chapter.Specialties: Global Leadership | Leading Change and Transformation | Strategy and Business Plan Development/Execution | Lab Management | Collaborations with External Partners | Supervising/Developing People | Medicinal chemistry | Drug Discovery | Lead generation I Structure Based Drug Design |CMC| CRO/CDMO externalization | Capital Improvements |
Listed skills include Drug Discovery, Medicinal Chemistry, Pharmaceutical Industry, Organic Chemistry, and 27 others.
Current workplace
Shon Pulley, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles · 32 years
Shon Pulley, Ph.D. work experience
A career timeline built from the work history available for this profile.
Senior Director Medicinal Chemistry
Jul 2022 - Jun 2023
Independent Consultant
Current
Solterra Consulting Llc
Mar 2021 - Present
Senior Director Research Technologies
Led a multi-disciplinary team accountable for process and analytical development, drug disposition/safety, pre-formulation and computational sciences. Enhanced the organizational approach to early research, managing upstream and downstream stakeholders to ensure continuity into development.• Optimized resource allocation to deliver milestones for ~30 portfolio projects on time and on budget.• Leveraged broad drug development experience to implement a knowledge management platform for electronic notebook (eLN), molecule registration, sample management and supporting discovery research data workflow (included establishing processes, training and quality management) which serves as the foundation for information tracking from inception to approval.• Drove the organization to focus on projects with higher probability of technical success by creating and implementing a technical asset assessment process that provides consistent risk/gaps analysis, leading teams to focus on critical tasks.• Identified laboratory infrastructure deficiencies, enabled a strategy to implement solutions, secured business plan funding, executed capital improvement to support strategic research functions (biopharma, microbiome, vaccine).
Mar 2019 - Feb 2021
Director Elanco Research Laboratories
Accountable for the Elanco Research Labs (ERL) and Lab Operations (> 50 FTE).• Created and implemented the ERL strategy uniting chemistry/biology, virology, bacteriology, drug disposition/safety, computational, enzyme research functions and laboratory operations in US and EU supporting research portfolio.• Managed organizational change by building discovery biology, and technologies functions to maximize efficiency of ERL teams. Coached and mentored junior scientists. Recruited and hired (9) diverse staff in ADME, assay development, formulation.• Co-Led and established a biopharma research strategy at Elanco (hired FTEs and secured funding).• Initiated external research collaboration with a Japanese Ag. Chem. using an internal asset.
Mar 2017 - Mar 2019
Director Companion Animal Research
Responsible for companion animal therapeutic area research. Aligned key cross functional stake holders to ensure alignment of research portfolio with customer needs.• Created companion animal research strategy and defined expected deliverable metrics with Sr. Management.• Defined targets, models, budget and resources along with key external partners to enable strategy supporting portfolio progression.• Led team of 4 scientist responsible for executing proof of concept studies for diabetes, OA pain, dermatology. • Accountable for and maintained external collaboration to complement internal parasitology research capabilities.
Apr 2016 - Feb 2017
Principal Research Scientist
Chemistry scientific lead for R&D team for companion animal parasiticides and therapeutics.• Responsible for leading an integrated chemistry, biology and ADME team with an external collaborator for the discovery of a novel treatment for canine heartworm.• Initiated collaborations with Japanese Ag Chem companies supporting parasiticide portfolio strategy.• Provided strategic and scientific leadership in collaboration with external partner to identify an NME for treatment of GI nematodes in cattle, resulting in a development candidate.• Provided chemistry leadership and strategic contributions to the companion animal Global Parasiticide Strategy for the selection and evaluation of internal and external compounds.• Developed a technical solution critical to the successful launch of Cheristin® in the US market.
Oct 2013 - Apr 2016
Oct 2011 - Oct 2013
Senior Research Chemist
D&M Continuous Solutions, Llc
Technology design and development for continuous flow chemistry applied to API process development• Developed a continuous flow Ir-catalyzed homogenous reductive amination
Aug 2010 - Oct 2011
Research Advisor
Project leader with biology colleagues and external collaborators in the progression of inhibitors of G-protein coupled receptors in oncology. Teams included internal and external collaborators from chemistry, biology, and drug dispositionTeam leader in collaboration with an external partner, charged with identifying a compound for target validation of a G-protein coupled receptor in the inhibition of painContributed to a strategic plan for compound acquisition and capital equipment purchase to support ion channel initiatives in collaboration with colleagues from biology and therapeutic area representativesKey member of core team responsible for delivering and training end-users on a global solution for lab supply and reagent management. Resulting in cost savings and increased safety complianceMentored and collaborated with external CRO chemists to support lab projects
Nov 2006 - Jun 2010
Principal Research Scientist
Scientific team leader for lead generation and optimization efforts targeting chemokine G-protein coupled receptors for oncology and inflammation. Partnered with biology, drug disposition, toxicology and governance colleagues to reach data driven and strategic decisions for these efforts. Co-sponsor for a Six Sigma project that designed and implemented a process for all internal drug discovery teams to request and receive standards for target validation using contract research resources.Co-recipient of 2005 Lilly Research Labs Presidents Award for a transformational process evaluating actives from a screen and identifying scaffolds with high probability of progressing to lead optimizationContributed to a structure based drug design effort for the serine protease DPP-IV for diabetes. Co-inventor on 3 patent applications related to this workSupervision of 1-2 M.S. level scientists and 2 external contract research chemists
Aug 2003 - 2006
Research And Development Scientist
Contributing team member of a large cross-functional and external partner collaboration charged with the identification of inhibitors of beta-secretase for the treatment of Alzheimer'sDesigned and implemented novel SAR for inhibitors of beta-secretase using structure based drug designManaged CRO chemistry resources for teamDirect supervision of 2 M.S. level scientists
2000 - 2003
~3 yrs
Assistant Professor
Assistant Professor of Organic ChemistrySynthesis of C-arylglycosides, biaryl ethers, and phenyl glycines using chromium carbene complexesSynthesis of (S,S)-IsodityrosineUndergraduate and Graduate teaching
1995 - 2000
~5 yrs
4 education records
Shon Pulley, Ph.D. education
Ph.D., Chemistry
Colorado State University
Executive Certificate- Kelly School Of Business, Business Of Life Sciences
Indiana University Bloomington
Post Doctoral, Organic Chemistry
Stanford University
Bs, Cum Laude, Chemistry
Utah State University
FAQ
Frequently asked questions about Shon Pulley, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Shon Pulley, Ph.D. work for?
Shon Pulley, Ph.D. works for ROME Therapeutics.
What is Shon Pulley, Ph.D.'s role at ROME Therapeutics?
Shon Pulley, Ph.D. is listed as Principal and Owner at SolTerra Consulting LLC | Pharmaceutical R&D | Drug Discovery | External Collaborations at ROME Therapeutics.
What is Shon Pulley, Ph.D.'s email address?
AeroLeads has found 3 work email signals at @elanco.com for Shon Pulley, Ph.D. at ROME Therapeutics.
Where is Shon Pulley, Ph.D. based?
Shon Pulley, Ph.D. is based in Trenton, South Carolina, United States while working with ROME Therapeutics.
What companies has Shon Pulley, Ph.D. worked for?
Shon Pulley, Ph.D. has worked for Rome Therapeutics, Solterra Consulting Llc, Elanco, D&M Continuous Solutions, Llc, and Eli Lilly And Company.
How can I contact Shon Pulley, Ph.D.?
You can use AeroLeads to view verified contact signals for Shon Pulley, Ph.D. at ROME Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Shon Pulley, Ph.D. attend?
Shon Pulley, Ph.D. holds Ph.D., Chemistry from Colorado State University.
What skills is Shon Pulley, Ph.D. known for?
Shon Pulley, Ph.D. is listed with skills including Drug Discovery, Medicinal Chemistry, Pharmaceutical Industry, Organic Chemistry, Chemistry, Drug Design, Drug Development, and Synthetic Organic Chemistry.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial